Life Sciences Archive » November, 2007

Life Sciences - November, 2007

144 articles

• Ruling Over Serevent In Glaxo's Favor Will Stand
• Warner Chilcott Succeeds With Free Sample Defense
• Lawmaker Urges FDA Not To Allow Off-Label Loophole
• Genentech's Plan To Restrict Avastin Under Scrutiny
• Supreme Court Case Pits FDA Against State Courts
• Abbott Suffers Blows In Cordis Stent Feud
• Barr Settles With FTC Over Warner Chilcott Pact
• AstraZeneca Loses Bid To Toss Strict Liability Claims
• FDA Panel Warns Of Provigil Safety For Kids
• Court Nixes Bid To Boot Lead Avandia Plaintiff
• Judge OKs Punitive Damages Claims In Mirapex Suits
• FDA Advisers Recommend More Flu Drug Warnings
• Nellson Gets Approval To Spend Cash Collateral
• Schering Sues Another Generics Co. Over Clarinex
• Cordis' Stent Technology Triggers Patent Suits
• U.S., EU Move To Harmonize Drug Approval Scheme
• Nifedipine Plaintiffs Win Class Certification Bid
• Q&A With McAndrews, Held & Malloy's Thomas J. Wimbiscus
• Stanford Scores Claim Constructs In HIV Patent Case
• Pfizer Wins Discovery Spat In Lipitor Off-Market Suit
• Biomedino Denied Cert In Blood-Cleaning Patent Suit
• German Court Invalidates Omega-3 Drug Patent
• Talks Stall In Pfizer's Nigerian Drug Trial Case
• Ousted Director Says Novartis Inflated Famvir's Value
• Roche Wages Patent Fight Over Diabetes Test Strips
• High Court Declines To Hear Patent Correction Case
• Abbott Fires Off Suit Over Seizure Treatment
• High Court Refuses Appeal Of Drug Imports Dispute
• Wyeth Loses Bid To Toss Failure-To-Warn Claims
• Judge Tosses State's Suit Against Pfizer Over Rezulin
• FDA Sniffs Asthma Drugs Over Child Safety Concerns
• Injunction Deals Another Blow To Stryker
• DOJ Fights Body Armor Firm's Bid To Settle Suits
• Ark. Goes After J&J For Risperdal Marketing, Costs
• CooperVision, Ciba Settle Contact Lens Dispute
• FDA Asks Pfizer For More Data On Anti-Smoking Drug
• Medtronic Denies Reported $130M Settlement
• Novartis Unit Hits Roche With HIV Patent Suit
• Parker Poe IP Team Sets Up Shop At Troutman
• Alza Wins Dismissal Of Ditropan Suit
• Appeals Court Hands Victory To Merck
• Forest Labs Strikes Back At Complaint Over Lexapro
• Vitol Agrees To Pay $17.5M In Oil-For-Food Case
• AstraZeneca's Nexium Patent Remains Valid
• Abbott Ordered To Produce Redacted LifeScan Deal
• Judge Tosses Expert Testimony From Celebrex Case
• Guidant Defibrillator Deal Expanded To $240M
• Impax Fights Patent Suit Over Pain Reliever
• J&J, Boston Scientific Sued Over Stent Patent
• Guidant, ECRI Settle Dispute Over Pricing Service
• Sanofi Obesity Drug Can Cause Mood Disorders: Study
• With Divestitures, Schering Gets OK To Buy Rival
• FTC To Tackle Mergers, Healthcare, VoIP In 08
• Nellson Cleared In Probe Over Conduct With Creditors
• Judge Approves More Ovcon 35 Settlements
• Glaxo Silenced Avandia Critic: Senate Report
• Judge Denies Bid To Move Guidant Suit To State Court
• Employees' Religious Beliefs In Health Care Settings
• Judge Nixes Becton's Inequitable Conduct Theory
• Knobbe Martens Opens Shop In Washington
• Wyeth Hit With Securities Suit Over Menopause Drug
• Stryker Pays $16.6M To Quell Qui Tam Allegations
• Judge Tosses Claims Against Merck In Eye Drug Suit
• Judge Bounces Some Fraud Claims In Mirapex MDL
• Mircera Gets FDA Approval But Will Not Be Launched
• Glaxo Adds Heart Attack Warning To Avandia
• First Circuit Vacates Dismissal Of Pfizer Suit
• FDA Oversight Of Clinical Trials: Changes Loom
• Walgreen Sued Over Baby's Death From Cold Medicine
• FDA Brushes Up On Committee Transparency
• Chevron Latest To Settle Oil-For-Food Charges
• Boston Scientific, Cordis Seek New Trial In Stent Case
• Pfizer Ordered To Reveal Bextra Sales Rep Bonuses
• Sanofi Slapped With Securities Suit Over Obesity Drug
• Merck Strikes Back In Fosamax Case
• Medtronic, Kyphon Close Merger, Settle Patent Suit
• High Court Won't Hear Stryker, Acumed Patent Case
• Novartis Wants To Question Bone Patients' Doctors
• Orion Targets Sun Over Generic Parkinson's Drug
• Pfizer Pays $135M To Bow Out Of Marketing Deal
• High Court Denies Review Of Spinal Screw Patent Suit
• Judge Orders Inspection Of Govt. Docs In Abbott Suit
• Federal Circuit Dismisses Appeal Over Jurisdiction
• Investors Sue Medtronic Over Defibrillation Device
• Amgen Faces Suit, Subpoenas Over Alleged Tying
• Trial Court Deals Cardia Blow After Appellate Reversal
• Fraud Claims Against aaiPharma Auditor Jettisoned
• St. Jude Defibrillator Lead Faces Scrutiny
• Anemia Drugs May Not Be Safe At Low Levels: FDA
• Medicare Advantage Marketing Abuses
• Ovcon Maker Settles Final Authorized Generics Suit
• Merck Will Look At Claims Before Shelling Out $4.85B
• Vioxx Deal To Affect Other Merck Litigation: Experts
• Settling Vioxx Claims Wasn't An About-Face: Merck
• Cephalon To Pay $425M To End Federal Investigation
• Vioxx Deal Yields Lawyer Payday
• Orchid Says Roche's Boniva Patents Invalid
• Staph Infections In The Workplace
• Stunning Lawyers, Merck Plans To Settle Vioxx Cases
• Takeda Wins Costs Dispute With Alphapharm
• Astellas, Boehringer, Ranbaxy Resolve Flomax Spat
• Baxter Wins $14.2M, Clearing Fresenius To Appeal
• Judge Throws Hernia Patch Case Back To N.J.
• Court Shoots Down AstraZeneca Move For Dismissals
• Judge Levies Fees, Sanctions In DES Lawyer Spat
• Plaintiff Drops Paxil Suit Against GlaxoSmithKline
• Mylan Says Novartis' Lotrel Patent Invalid
• Medicare's New Policy For Recalled, Replaced Devices
• Bausch & Lomb Plaintiffs Try To Jump Twombly Hurdle
• PTO Ruling: The Court's Opinion
• Direct Purchasers Win Class In Ovcon Antitrust Suit
• PTO Officials Called For Depositions In Rules Battle
• Bayer Alleges Patent Infringement Over Yaz
• Judge Allows Bulk Of J&J Suit To Go Forward
• Judge Names Lead Plaintiff In Biotech Suit
• BMS, AstraZeneca Pay AWP Plaintiffs Double Damages
• McNeil Appeals $5M Tylenol Verdict A Second Time
• MDL Panel Strips Aredia Complaint Of Some Charges
• Schering-Plough Officers Settle Shareholder Suit
• Judge Keeps Privileged Ditropan Documents Sealed
• Circuit Won't Revive Talking Defibrillator Suit
• Medco, Merck Fight Pharmacies' Take On Per Se Rule
• Japanese Tamiflu Demand Slows In Wake Of Deaths
• Bayer Suspends Trasylol Marketing At FDA's Behest
• J&J Overtime Suit To Remain In Federal Court: Judge
• Celgene Wants Barr's Antitrust Claims Put On Hold
• Mylan Plaintiffs Make New Bid For Treble Damages
• Lupin Fires Back At Novartis In Lotrel Patent Spat
• Drug-Eluting Stents Pose No Greater Risk: Study
• U.S. Says It Need Not Produce Docs In AWP Case
• Patent Malpractice Suits A Growing Threat
• Research Co. Still On Hook In Product Liability Suit
• Joint Makers Paid More Than $200M In Kickback Probe
• Celgene, Novartis File Ritalin Patent Suit
• Drug Companies Draw $22M Fine From KFTC
• Cobalt Challenges Patents For AstraZeneca's Crestor
• Boston Scientific Liable For Stent Infringement: Jury
• NAACP Joins Race Bias Action Against Eli Lilly
• Compulsory Drug Licensing Scheme Inches Forward
• AstraZeneca Settles Dispute Over Prilosec OTC
• Fosamax Judge Nixes Bid For Evidentiary Hearing
• Health Care Cos. Took $1.5B Hit From DOJ In 07
• GAO Slams FDA For Lax Monitoring Of Foreign Drugs
• Government Whistleblowers Got $177M In FY07